Charoenwisedsil Rachata, Lawpoolsri Saranath, Rattanaumpawan Pinyo, Goh Daniel Y T, Flaherty Gerard T, Ngamprasertchai Thundon
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Hum Vaccin Immunother. 2025 Dec;21(1):2491994. doi: 10.1080/21645515.2025.2491994. Epub 2025 Apr 22.
Dengue vaccines face significant challenges, including safety concerns, which contribute to vaccine hesitancy. Addressing this complex issue requires targeted strategies to overcome existing barriers. Through an extensive review of current evidence, we identified key factors contributing to vaccine hesitancy and explored strategies to enhance global vaccine uptake. Four conceptual models and five assessment tools were identified to understand and measure vaccine hesitancy. Among the factors, "confidence" emerged as the most influential, followed by "complacency." Vaccine acceptance rates varied widely, ranging from 53% to 95%, depending on the region and population. Key determinants included population characteristics, concerns about efficacy and safety, among others. A comprehensive understanding of these factors is essential to improve vaccine acceptance, support dengue prevention efforts, and ensure public health success.
登革热疫苗面临重大挑战,包括安全问题,这导致了疫苗犹豫现象。解决这一复杂问题需要有针对性的策略来克服现有障碍。通过对当前证据的广泛审查,我们确定了导致疫苗犹豫的关键因素,并探索了提高全球疫苗接种率的策略。确定了四个概念模型和五个评估工具,以理解和衡量疫苗犹豫现象。在这些因素中,“信心”成为最具影响力的因素,其次是“自满”。疫苗接受率差异很大,根据地区和人群的不同,从53%到95%不等。关键决定因素包括人口特征、对效力和安全性的担忧等。全面了解这些因素对于提高疫苗接受度、支持登革热预防工作以及确保公共卫生成功至关重要。